Moderna Inc on Thursday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion. The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases. Moderna on Thursday forecast additional purchases of roughly $500 million.
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`